BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4072263)

  • 21. Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin.
    Gaeta GB; Adinolfi LE; Utili R; Tripodi MF; Abernathy CO
    Life Sci; 1986 Aug; 39(5):453-60. PubMed ID: 3526067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note.
    Abernathy CO; Lukacs L; Zimmerman HJ
    Mech Ageing Dev; 1980 Jan; 12(1):1-6. PubMed ID: 7354660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes.
    Villa P; Cova D; De Francesco L; Guaitani A; Palladini G; Perego R
    Toxicology; 1992; 73(2):179-89. PubMed ID: 1609428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The detection of cytotoxicity produced by short-lived reactive intermediates: a study with bromobenzene.
    Horner SA; Fry JR; Clothier RH; Balls M
    Xenobiotica; 1987 Jun; 17(6):777-82. PubMed ID: 3498266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
    Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
    Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat.
    Lu X; Tian Y; Lian X; Jin Y; Jin T; Zhao Q; Hu B; Shen X; Fan X
    Food Chem Toxicol; 2014 Mar; 65():343-55. PubMed ID: 24412560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril cytotoxicity in primary cultures of rat hepatocytes. I. Effects of cytochrome P450 inducers and inhibitors.
    Jurima-Romet M; Huang HS; Paul CJ; Thomas BH
    Toxicol Lett; 1991 Nov; 58(3):257-67. PubMed ID: 1659756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cocaine toxicity in cultured rat hepatocytes.
    Roberts SM; Pounds JG; James RC
    Toxicol Lett; 1990 Feb; 50(2-3):283-8. PubMed ID: 2309247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative toxicities of several nonsteroidal antiinflammatory compounds in primary cultures of rat hepatocytes.
    Sorensen EM; Acosta D
    J Toxicol Environ Health; 1985; 16(3-4):425-40. PubMed ID: 4087309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of flavonoids on drug-induced hepatotoxicity in vitro.
    Davila JC; Lenherr A; Acosta D
    Toxicology; 1989 Aug; 57(3):267-86. PubMed ID: 2756528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of serum-free medium on cytochrome P450-dependent metabolism and toxicity in rat cultured hepatocytes.
    Hammond AH; Fry JR
    Biochem Pharmacol; 1992 Oct; 44(7):1461-4. PubMed ID: 1417966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity assessment of papaverine hydrochloride and papaverine-derived metabolites in primary cultures of rat hepatocytes.
    Davila JC; Reddy CG; Davis PJ; Acosta D
    In Vitro Cell Dev Biol; 1990 May; 26(5):515-24. PubMed ID: 2351644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of hepatocyte co-cultures in the assessment of drug toxicity from chronic exposure.
    Ratanasavanh D; Baffet G; Latinier MF; Rissel M; Guillouzo A
    Xenobiotica; 1988 Jun; 18(6):765-71. PubMed ID: 3420952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro comparative toxicity of selected drugs and chemicals in HeLa cells, Chang liver cells, and rat hepatocytes.
    Ekwall B; Acosta D
    Drug Chem Toxicol; 1982; 5(3):219-31. PubMed ID: 7151717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of cytotoxicity of ticrynafen in primary cultures of rat liver cells.
    Acosta D; Mitchell DB; Santone KS; Bock A; Lewis W
    Toxicol Lett; 1982 Mar; 10(4):385-8. PubMed ID: 7089992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo effects of erythromycin, oleandomycin and erythralosamine derivatives on hepatic cytochrome P-450.
    Delaforge M; Sartori E
    Biochem Pharmacol; 1990 Jul; 40(2):223-8. PubMed ID: 2375764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of roxithromycin, a new semisynthetic macrolide, and two erythromycins on drug metabolizing enzymes in rat liver.
    Villa P; Sassella D; Corada M; Bartosek I
    J Antibiot (Tokyo); 1988 Apr; 41(4):563-9. PubMed ID: 3372362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of hepatocyte cultures for preliminary metabolism and cytotoxicity studies of a new anti-hypertensive agent, oxaminozoline.
    Guillouzo A; Grislain L; Ratanasavanh D; Mocquard MT; Begue JM; Du Vignaud P; Bromet N; Genissel P; Beau B
    Xenobiotica; 1988 Jun; 18(6):757-63. PubMed ID: 3420951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative cytotoxicity of psychotropic drugs in cultured rat hepatocytes.
    Boelsterli UA; Bouis P; Donatsch P
    Cell Biol Toxicol; 1987 Sep; 3(3):231-50. PubMed ID: 3507257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of megamitochondria by some chemicals inducing oxidative stress in primary cultured rat hepatocytes.
    Karbowski M; Kurono C; Nishizawa Y; Horie Y; Soji T; Wakabayashi T
    Biochim Biophys Acta; 1997 Nov; 1349(3):242-50. PubMed ID: 9434138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.